1. Home
  2. ELDN vs CDZI Comparison

ELDN vs CDZI Comparison

Compare ELDN & CDZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • CDZI
  • Stock Information
  • Founded
  • ELDN 2004
  • CDZI 1983
  • Country
  • ELDN United States
  • CDZI United States
  • Employees
  • ELDN N/A
  • CDZI N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • CDZI Water Supply
  • Sector
  • ELDN Health Care
  • CDZI Utilities
  • Exchange
  • ELDN Nasdaq
  • CDZI Nasdaq
  • Market Cap
  • ELDN 232.4M
  • CDZI 247.1M
  • IPO Year
  • ELDN N/A
  • CDZI N/A
  • Fundamental
  • Price
  • ELDN $3.39
  • CDZI $2.93
  • Analyst Decision
  • ELDN Strong Buy
  • CDZI
  • Analyst Count
  • ELDN 1
  • CDZI 0
  • Target Price
  • ELDN $16.00
  • CDZI N/A
  • AVG Volume (30 Days)
  • ELDN 261.8K
  • CDZI 794.2K
  • Earning Date
  • ELDN 03-20-2025
  • CDZI 05-13-2025
  • Dividend Yield
  • ELDN N/A
  • CDZI N/A
  • EPS Growth
  • ELDN N/A
  • CDZI N/A
  • EPS
  • ELDN N/A
  • CDZI N/A
  • Revenue
  • ELDN N/A
  • CDZI $9,608,000.00
  • Revenue This Year
  • ELDN N/A
  • CDZI $581.27
  • Revenue Next Year
  • ELDN N/A
  • CDZI $27.69
  • P/E Ratio
  • ELDN N/A
  • CDZI N/A
  • Revenue Growth
  • ELDN N/A
  • CDZI 382.57
  • 52 Week Low
  • ELDN $1.52
  • CDZI $2.12
  • 52 Week High
  • ELDN $5.54
  • CDZI $5.68
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 32.13
  • CDZI 23.82
  • Support Level
  • ELDN $3.22
  • CDZI $3.34
  • Resistance Level
  • ELDN $3.44
  • CDZI $3.53
  • Average True Range (ATR)
  • ELDN 0.18
  • CDZI 0.15
  • MACD
  • ELDN -0.01
  • CDZI -0.02
  • Stochastic Oscillator
  • ELDN 20.31
  • CDZI 6.49

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About CDZI CADIZ Inc.

Cadiz Inc is a land and water resource development company in California. Its primary business is to acquire and develop land with water resources for various uses, including groundwater supply, groundwater storage, and agriculture. The company focuses on the development of the Cadiz Valley Water Conservation, Recovery and Storage Project which will capture and conserve native groundwater currently being lost to evaporation from the aquifer system beneath the property of Cadiz and Fenner valleys of eastern San Bernardino County, and deliver it to water providers throughout Southern California. The company operates in two segment- Land and Water Resources and ATEC Water Systems LLC.

Share on Social Networks: